These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 223531)

  • 1. Herpetic ganglionic latency. Aciclovir and vidarabine therapy.
    Pavan-Langston D; Park NH; Lass JH
    Arch Ophthalmol; 1979 Aug; 97(8):1508-10. PubMed ID: 223531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acylovir in oral and ganglionic herpes simplex virus infections.
    Park NH; Pavan-Langston D; McLean SL
    J Infect Dis; 1979 Nov; 140(5):802-6. PubMed ID: 316819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes simplex virus in vitro.
    Park NH; Pavan-Langston D; Declercq E
    Am J Med; 1982 Jul; 73(1A):151-4. PubMed ID: 6285706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
    Svennerholm B; Vahlne A; Lycke E
    Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
    Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglionic herpes simplex and systemic acyclovir.
    Pavan-Langston D; Park NH; Hettinger M
    Arch Ophthalmol; 1981 Aug; 99(8):1417-9. PubMed ID: 6266375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the antiherpetic activity of acyclovir in rabbits.
    Trousdale MD; Nesburn AB
    Am J Med; 1982 Jul; 73(1A):155-60. PubMed ID: 6285707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclovir and vidarabine for the treatment of herpes simplex keratitis.
    Laibson PR; Pavan-Langston D; Yeakley WR; Lass J
    Am J Med; 1982 Jul; 73(1A):281-5. PubMed ID: 7102707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the effectiveness of levamisole on mice experimental herpetic keratitis. 1. Inhibition of trigeminal ganglionic latency of herpes simplex virus].
    Hiyama N
    Nippon Ganka Gakkai Zasshi; 1983; 87(5):346-51. PubMed ID: 6310977
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of HSV-1 DNA species from trigeminal ganglia of rabbits during acute and latent infections.
    Green MT; Qavi HB; SeGall GK
    Curr Eye Res; 1987 Jan; 6(1):85-9. PubMed ID: 3030658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against herpetic ocular disease in an outbred mouse model.
    Metcalf JF; Whitley RJ
    Curr Eye Res; 1987 Jan; 6(1):167-71. PubMed ID: 3030641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes.
    Trousdale MD; Nesburn AB; Su TL; Lopez C; Watanabe KA; Fox JJ
    Antimicrob Agents Chemother; 1983 Jun; 23(6):808-13. PubMed ID: 6311085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir and vidarabine in the treatment of ulcerative herpes simplex keratitis.
    Pavan-Langston D; Lass J; Hettinger M; Udell I
    Am J Ophthalmol; 1981 Dec; 92(6):829-35. PubMed ID: 7032303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
    Smith KO; Kennell WL; Poirier RH; Lynd FT
    Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex keratitis.
    Kaufman HE; Centifanto-Fitzgerald YM; Varnell ED
    Ophthalmology; 1983 Jun; 90(6):700-6. PubMed ID: 6310466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Arch Virol; 1980; 65(3-4):237-46. PubMed ID: 6251784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ; Gray JJ
    Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
    O'Brien WJ; Taylor JL
    Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclic antimetabolite therapy of experimental herpes simplex keratitis.
    Pavan-Langston D; Campbell R; Lass J
    Am J Ophthalmol; 1978 Nov; 86(5):618-23. PubMed ID: 213976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.